The CYP19A1 (TTTA)n Repeat Polymorphism May Affect the Prostate Cancer Risk: Evidence from a Meta-Analysis

Abnormal aromatase (CYP19A1) expression may participate in prostate cancer (PCa) carcinogenesis. However, the results of studies on the CYP19A1 gene polymorphisms and PCa are conflicting. This meta-analysis aimed to systematically evaluate the associations between the CYP19A1 Arg264Cys polymorphism...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Lei, Liu, Yanan, Liu, Lijun, Shao, Shixiu, Cao, Yanwei, Guo, Jiaming, Niu, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Prostatic Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161905/
https://www.ncbi.nlm.nih.gov/pubmed/34036824
http://dx.doi.org/10.1177/15579883211017033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161905/
https://www.ncbi.nlm.nih.gov/pubmed/34036824
http://dx.doi.org/10.1177/15579883211017033

Ejemplares similares